Park Dae-Hwan, Choi Sung-Seok
Department of Plastic and Reconstructive Surgery, College of Medicine, University of Daegu Catholic, #3056-6 Taemyung 4-dong, Namgu, Daegu 705-825, Korea.
Ann Plast Surg. 2002 Dec;49(6):604-11. doi: 10.1097/00000637-200212000-00009.
Thirteen patients underwent reoperation for recurrent blepharoptosis using the orbicularis oculi muscle flap or the frontalis musculofascial flap. The orbicularis oculi muscle flap and the frontalis musculofascial flap are a modification of direct transplantation of the frontalis muscle to the tarsal plate. This is based on an anatomic study showing that the frontalis muscle and its fascia are connected with the orbicularis oculi muscle at the eyebrow region. The patients' previous blepharoptosis operations were frontalis muscle suspension with autogenous or alloplastic material. Their follow-up period ranged from 6 months to 10 years. The average interval between the patient's first frontalis suspension to their reoperation was 8.09 years. The selection of the muscle flaps was based on the extent of levator function of the patient. When the eyelid excursion was moderate (>4 mm), the orbicularis oculi muscle flap was used. For patients with minimal or weak eyelid excursion (<3 mm), the frontalis musculofascial flap was used. Eleven patients (91.6%) gained levator excursion of more than 7 mm and reduced the height difference of both palpebral fissures by less than 2 mm after the reoperation. After an average follow-up of 20 months, 11 patients (14 eyelids) recorded satisfactory results. This is based on the criteria of Souther, and Jordan and Anderson. The overall results were more than satisfactory. Even though 2 patients reported poor results, there was no complete failure in this series. The authors' technique offers several advantages over conventional frontalis muscle suspension: it is a simple technique that has a good operative field, there is no donor morbidity and less complications, and asymmetrical supratarsal folding, eyelid notching, lagophthalmus, and abnormal eyebrow position that can occur after a frontalis muscle suspension can be avoided. In summary, the orbicularis oculi muscle flap or the frontalis musculofascial flap are considered for patients with recurrent blepharoptosis after frontalis muscle suspension.
13例复发性上睑下垂患者接受了使用眼轮匝肌瓣或额肌肌筋膜瓣的再次手术。眼轮匝肌瓣和额肌肌筋膜瓣是额肌直接移植到睑板的一种改良方法。这是基于一项解剖学研究,该研究表明额肌及其筋膜在眉部区域与眼轮匝肌相连。患者之前的上睑下垂手术为使用自体或异体材料的额肌悬吊术。他们的随访期为6个月至10年。患者首次额肌悬吊至再次手术的平均间隔时间为8.09年。肌瓣的选择基于患者提上睑肌功能的程度。当眼睑移动度适中(>4mm)时,使用眼轮匝肌瓣。对于眼睑移动度极小或较弱(<3mm)的患者,使用额肌肌筋膜瓣。11例患者(91.6%)再次手术后提上睑肌移动度超过7mm,双侧睑裂高度差减小不到2mm。平均随访20个月后,11例患者(14只眼)取得了满意的效果。这是根据索瑟尔、乔丹和安德森的标准判定的。总体结果非常令人满意。尽管有2例患者报告效果不佳,但该系列中没有完全失败的情况。与传统的额肌悬吊术相比,作者的技术具有几个优点:它是一种简单的技术,术野良好,没有供区并发症且并发症较少,并且可以避免额肌悬吊术后可能出现的不对称性睑板上折叠、眼睑切迹、兔眼和异常眉位。总之,对于额肌悬吊术后复发性上睑下垂的患者,可考虑使用眼轮匝肌瓣或额肌肌筋膜瓣。